Skip to main content
. 2018 Feb 28;9(6):959–967. doi: 10.7150/jca.22787

Table 1.

Clinicopathological Parameters of PCa and BPH patients

Variables PCa BPH P value
Number of cases 386 60
Age(years)
Mean ± SD 68.52±7.11 68.08±6.65 0.437
Range 46-79 47-82
BMI (kg/m2)
Mean ± SD 25.77±4.42 26.30±3.99 0.352
Range 17.02-33.25 17.06-34.79
Prostate volume(ml)
Mean ± SD 40.45±8.47 42.70±10.14 0.596
Range 20-59 35-100
PSA level(ng/ml)
Mean ± SD 19.50±13.53 4.83±3.016 <0.001
Range 2.03-62.27 0.54-15.05
Paxillin expression,n(%) <0.001
- 89 58
+ 94 2
++ 102 0
+++ 101 0
PSAD(ng/ml·cm3)
Mean ± SD 0.52±0.44
Range 0.06-2.22
Percentage of positive biopsiesa [n (%)]
<50% 236(61.1)
≥50% 150(38.9)
cT stage [n (%)]
T1 60(15.5)
T2 259(67.1)
T3 67(17.4)
Gleason Score[n (%)]
<7 99(25.6)
7 189(49.0)
>7 98(25.4)
Lymph node metastasis[n (%)]
Yes 129(33.4)
No 257(66.6)
Extracapsular extension[n (%)]
Yes 67(17.4)
No 319(82.6)
Seminal vesicle invasion[n (%)]
Yes 21(5.4)
No 365(94.6)
Positive surgical margin [n (%)]
Yes 45(11.7)
No 341(88.3)